Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes |
| |
Authors: | D M Kusters R Huijgen J C Defesche M N Vissers I Kindt B A Hutten J J P Kastelein |
| |
Institution: | 1Department of Vascular Medicine, Academic Medical Center, room F4-212, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands ;2Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, the Netherlands ;3Foundation for the Identification of Persons with Inherited Hypercholesterolemia, Amsterdam, the Netherlands |
| |
Abstract: | BackgroundIn the Netherlands, a screening programme was set up in 1994 in order to identify all patients with familial hypercholesterolaemia (FH). After 15 years of screening, we evaluated the geographical distribution, possible founder effects and clinical phenotype of the 12 most prevalent FH gene mutations.MethodsPatients who carried one of the 12 most prevalent mutations, index cases and those identified between 1994 and 2009 through the screening programme and whose postal code was known were included in the study. Low-density lipoprotein cholesterol (LDL-C) levels at the time of screening were retrieved. The prevalence of identified FH patients in each postal code area was calculated and visualised in different maps.ResultsA total of 10,889 patients were included in the study. Mean untreated LDL-C levels ranged from 4.4 to 6.4 mmol/l. For almost all mutations, a region of high prevalence could be observed. In total, 51 homozygous patients were identified in the Netherlands, of which 13 true homozygous for one of the 12 most prevalent mutations. The majority of them were living in high-prevalence areas for that specific mutation.ConclusionsPhenotypes with regard to LDL-C levels varied between the 12 most prevalent FH mutations. For most of these mutations, a founder effect was observed. Our observations can have implications with regard to the efficiency of molecular screening and physician’s perception of FH and to the understanding of the prevalence and distribution of homozygous patients in the Netherlands. |
| |
Keywords: | Familial hypercholesterolemia LDL cholesterol LDL receptor gene ApoB gene Genetic screening Founder effect Homozygosity |
本文献已被 SpringerLink 等数据库收录! |
|